189 related articles for article (PubMed ID: 17222321)
1. Clearance of HCV improves insulin resistance, beta-cell function, and hepatic expression of insulin receptor substrate 1 and 2.
Kawaguchi T; Ide T; Taniguchi E; Hirano E; Itou M; Sumie S; Nagao Y; Yanagimoto C; Hanada S; Koga H; Sata M
Am J Gastroenterol; 2007 Mar; 102(3):570-6. PubMed ID: 17222321
[TBL] [Abstract][Full Text] [Related]
2. Eradication of hepatitis C virus by interferon improves whole-body insulin resistance and hyperinsulinaemia in patients with chronic hepatitis C.
Kawaguchi Y; Mizuta T; Oza N; Takahashi H; Ario K; Yoshimura T; Eguchi Y; Ozaki I; Hisatomi A; Fujimoto K
Liver Int; 2009 Jul; 29(6):871-7. PubMed ID: 19302179
[TBL] [Abstract][Full Text] [Related]
3. Time course of insulin resistance during antiviral therapy in non-diabetic, non-cirrhotic patients with genotype 1 HCV infection.
Petta S; Cammà C; Di Marco V; Cabibi D; Ciminnisi S; Caldarella R; Licata A; Massenti MF; Marchesini G; Craxì A
Antivir Ther; 2009; 14(5):631-9. PubMed ID: 19704165
[TBL] [Abstract][Full Text] [Related]
4. Insulin resistance and response to therapy in patients infected with chronic hepatitis C virus genotypes 2 and 3.
Poustchi H; Negro F; Hui J; Cua IH; Brandt LR; Kench JG; George J
J Hepatol; 2008 Jan; 48(1):28-34. PubMed ID: 17977612
[TBL] [Abstract][Full Text] [Related]
5. Association of lipid profiles with hepatitis C viral load in chronic hepatitis C patients with genotype 1 or 2 infection.
Hsu CS; Liu CH; Liu CJ; Wang CC; Chen CL; Lai MY; Chen PJ; Chen DS; Kao JH
Am J Gastroenterol; 2009 Mar; 104(3):598-604. PubMed ID: 19262519
[TBL] [Abstract][Full Text] [Related]
6. Hepatitis C virus directly associates with insulin resistance independent of the visceral fat area in nonobese and nondiabetic patients.
Yoneda M; Saito S; Ikeda T; Fujita K; Mawatari H; Kirikoshi H; Inamori M; Nozaki Y; Akiyama T; Takahashi H; Abe Y; Kubota K; Iwasaki T; Terauchi Y; Togo S; Nakajima A
J Viral Hepat; 2007 Sep; 14(9):600-7. PubMed ID: 17697011
[TBL] [Abstract][Full Text] [Related]
7. Involvement of the PA28gamma-dependent pathway in insulin resistance induced by hepatitis C virus core protein.
Miyamoto H; Moriishi K; Moriya K; Murata S; Tanaka K; Suzuki T; Miyamura T; Koike K; Matsuura Y
J Virol; 2007 Feb; 81(4):1727-35. PubMed ID: 17135326
[TBL] [Abstract][Full Text] [Related]
8. Insulin resistance and diabetes increase fibrosis in the liver of patients with genotype 1 HCV infection.
Petta S; Cammà C; Di Marco V; Alessi N; Cabibi D; Caldarella R; Licata A; Massenti F; Tarantino G; Marchesini G; Craxì A
Am J Gastroenterol; 2008 May; 103(5):1136-44. PubMed ID: 18477344
[TBL] [Abstract][Full Text] [Related]
9. Insulin resistance in chronic hepatitis B virus infection.
Kumar M; Choudhury A; Manglik N; Hissar S; Rastogi A; Sakhuja P; Sarin SK
Am J Gastroenterol; 2009 Jan; 104(1):76-82. PubMed ID: 19098853
[TBL] [Abstract][Full Text] [Related]
10. Serum HCV RNA levels and HCV genotype do not affect insulin resistance in nondiabetic patients with chronic hepatitis C: a multicentre study.
Tsochatzis E; Manolakopoulos S; Papatheodoridis GV; Hadziyannis E; Triantos C; Zisimopoulos K; Goulis I; Tzourmakliotis D; Akriviadis E; Manesis EK; Archimandritis AJ
Aliment Pharmacol Ther; 2009 Nov; 30(9):947-54. PubMed ID: 19604179
[TBL] [Abstract][Full Text] [Related]
11. High hepatitis C viral load is associated with insulin resistance in patients with chronic hepatitis C.
Hsu CS; Liu CJ; Liu CH; Wang CC; Chen CL; Lai MY; Chen PJ; Kao JH; Chen DS
Liver Int; 2008 Feb; 28(2):271-7. PubMed ID: 18028320
[TBL] [Abstract][Full Text] [Related]
12. Association between liver fibrosis and insulin sensitivity in chronic hepatitis C patients.
Taura N; Ichikawa T; Hamasaki K; Nakao K; Nishimura D; Goto T; Fukuta M; Kawashimo H; Fujimoto M; Kusumoto K; Motoyoshi Y; Shibata H; Abiru N; Yamasaki H; Eguchi K
Am J Gastroenterol; 2006 Dec; 101(12):2752-9. PubMed ID: 17026566
[TBL] [Abstract][Full Text] [Related]
13. Insulin resistance in chronic hepatitis C: association with genotypes 1 and 4, serum HCV RNA level, and liver fibrosis.
Moucari R; Asselah T; Cazals-Hatem D; Voitot H; Boyer N; Ripault MP; Sobesky R; Martinot-Peignoux M; Maylin S; Nicolas-Chanoine MH; Paradis V; Vidaud M; Valla D; Bedossa P; Marcellin P
Gastroenterology; 2008 Feb; 134(2):416-23. PubMed ID: 18164296
[TBL] [Abstract][Full Text] [Related]
14. Amino acid substitutions in the hepatitis C virus core region of genotype 1b are the important predictor of severe insulin resistance in patients without cirrhosis and diabetes mellitus.
Akuta N; Suzuki F; Hirakawa M; Kawamura Y; Yatsuji H; Sezaki H; Suzuki Y; Hosaka T; Kobayashi M; Kobayashi M; Saitoh S; Arase Y; Ikeda K; Kumada H
J Med Virol; 2009 Jun; 81(6):1032-9. PubMed ID: 19382270
[TBL] [Abstract][Full Text] [Related]
15. Hepatitis C virus replicates in the liver of patients who have a sustained response to antiviral treatment.
Castillo I; Rodríguez-Iñigo E; López-Alcorocho JM; Pardo M; Bartolomé J; Carreño V
Clin Infect Dis; 2006 Nov; 43(10):1277-83. PubMed ID: 17051492
[TBL] [Abstract][Full Text] [Related]
16. A 5-year prospective study of the late resolution of chronic hepatitis C after antiviral therapy.
Annicchiarico BE; Siciliano M; Avolio AW; Grillo RL; Bombardieri G
Aliment Pharmacol Ther; 2007 May; 25(9):1039-46. PubMed ID: 17439504
[TBL] [Abstract][Full Text] [Related]
17. Hepatic insulin resistance is associated with increased apoptosis and fibrogenesis in nonalcoholic steatohepatitis and chronic hepatitis C.
García-Monzón C; Lo Iacono O; Mayoral R; González-Rodríguez A; Miquilena-Colina ME; Lozano-Rodríguez T; García-Pozo L; Vargas-Castrillón J; Casado M; Boscá L; Valverde AM; Martín-Sanz P
J Hepatol; 2011 Jan; 54(1):142-52. PubMed ID: 20888662
[TBL] [Abstract][Full Text] [Related]
18. Determination of the impact of hepatitis C virus on insulin resistance and arterial stiffness in hemodialysis patients.
Adam FU; Torun D; Yigit F; Ozelsancak R; Sezer S; Ozdemir FN; Haberal M
Ren Fail; 2008; 30(4):411-5. PubMed ID: 18569915
[TBL] [Abstract][Full Text] [Related]
19. Immunohistochemical staining of liver grafts with a monoclonal antibody against HCV-Envelope 2 for recurrent hepatitis C after living donor liver transplantation.
Sadamori H; Yagi T; Iwagaki H; Matsuda H; Shinoura S; Umeda Y; Ohara N; Yanai H; Ogino T; Tanaka N
J Gastroenterol Hepatol; 2009 Apr; 24(4):574-80. PubMed ID: 19368635
[TBL] [Abstract][Full Text] [Related]
20. Virus-induced over-expression of protein phosphatase 2A inhibits insulin signalling in chronic hepatitis C.
Bernsmeier C; Duong FH; Christen V; Pugnale P; Negro F; Terracciano L; Heim MH
J Hepatol; 2008 Sep; 49(3):429-40. PubMed ID: 18486982
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
